Van Hulzen Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Sell
123,829
-5,441
-4% -$1.27M 2.25% 8
2025
Q4
$26.8M Buy
129,270
+1,378
+1% +$272K 1.96% 8
2025
Q3
$23.7M Buy
127,892
+895
+0.7% +$153K 1.76% 12
2025
Q2
$19.4M Buy
126,997
+8,155
+7% +$1.25M 1.62% 15
2025
Q1
$19.7M Sell
118,842
-34,558
-23% -$5.41M 1.8% 11
2024
Q4
$22.2M Buy
153,400
+1,807
+1% +$280K 1.62% 14
2024
Q3
$24.6M Sell
151,593
-21,888
-13% -$3.49M 1.78% 11
2024
Q2
$25.4M Buy
173,481
+1,686
+1% +$251K 1.7% 13
2024
Q1
$27.2M Sell
171,795
-1,515
-0.9% -$241K 1.79% 11
2023
Q4
$27.2M Sell
173,310
-1,498
-0.9% -$230K 1.91% 7
2023
Q3
$27.2M Buy
174,808
+8,337
+5% +$1.38M 2.09% 8
2023
Q2
$27.6M Buy
166,471
+4,728
+3% +$763K 2.35% 8
2023
Q1
$25.1M Buy
161,743
+39,032
+32% +$6.3M 2.36% 8
2022
Q4
$21.7M Buy
122,711
+5,795
+5% +$1M 2.5% 4
2022
Q3
$19.1M Sell
116,916
-35,973
-24% -$6.09M 2.36% 8
2022
Q2
$27.1M Buy
152,889
+124,768
+444% +$22.2M 3.24% 3
2022
Q1
$4.98M Sell
28,121
-441
-2% -$75K 0.53% 56
2021
Q4
$4.89M Sell
28,562
-49,392
-63% -$8.09M 0.53% 54
2021
Q3
$12.6M Buy
77,954
+4,854
+7% +$828K 1.87% 13
2021
Q2
$12M Buy
73,100
+2,127
+3% +$352K 1.81% 15
2021
Q1
$11.7M Sell
70,973
-57,274
-45% -$9.27M 1.86% 10
2020
Q4
$20.2M Sell
128,247
-9,666
-7% -$1.43M 3.06% 4
2020
Q3
$20.5M Sell
137,913
-18,758
-12% -$2.78M 3.09% 3
2020
Q2
$22M Buy
156,671
+5,656
+4% +$824K 3.31% 4
2020
Q1
$19.8M Buy
151,015
+49,978
+49% +$7.09M 4.26% 2
2019
Q4
$14.7M Sell
101,037
-6,658
-6% -$903K 2.85% 2
2019
Q3
$13.9M Buy
107,695
+4,114
+4% +$542K 2.94% 2
2019
Q2
$14.4M Buy
103,581
+6,846
+7% +$948K 3.15% 2
2019
Q1
$13.5M Buy
96,735
+6,829
+8% +$915K 3.64% 2
2018
Q4
$11.6M Buy
89,906
+1,552
+2% +$216K 3.36% 2
2018
Q3
$12.2M Buy
88,354
+4,759
+6% +$632K 3.25% 2
2018
Q2
$10.1M Buy
83,595
+38,651
+86% +$4.82M 3.01% 4
2018
Q1
$5.76M Buy
44,944
+12,373
+38% +$1.67M 1.76% 8
2017
Q4
$4.55M Buy
32,571
+18,969
+139% +$2.64M 1.38% 20
2017
Q3
$1.77M Buy
13,602
+8,762
+181% +$1.16M 0.6% 52
2017
Q2
$640K Buy
4,840
+560
+13% +$71.4K 0.25% 75
2017
Q1
$533K Sell
4,280
-2,200
-34% -$263K 0.24% 77
2016
Q4
$747K Buy
6,480
+2,200
+51% +$254K 0.35% 70
2016
Q3
$506K Sell
4,280
-16,263
-79% -$1.97M 0.27% 73
2016
Q2
$2.49M Sell
20,543
-13,690
-40% -$1.56M 1.42% 25
2016
Q1
$3.7M Buy
34,233
+2,989
+10% +$309K 2.11% 8
2015
Q4
$3.21M Buy
31,244
+1,300
+4% +$131K 2% 11
2015
Q3
$2.79M Buy
29,944
+17,176
+135% +$1.66M 1.81% 14
2015
Q2
$1.24M Buy
12,768
+700
+6% +$70.1K 0.67% 50
2015
Q1
$1.21M Buy
12,068
+664
+6% +$67.5K 0.74% 44
2014
Q4
$1.19M Buy
+11,404
New +$1.2M 0.83% 37
2014
Q2
Sell
-8,486
Closed -$834K 78
2014
Q1
$834K Buy
8,486
+627
+8% +$58.1K 0.84% 42
2013
Q4
$720K Buy
+7,859
New +$724K 0.62% 56

Other funds holding JNJ

Van Hulzen Asset Management's JNJ Position: Q1 2026 in Review

Van Hulzen Asset Management reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q1 2026, selling an estimated $1.27M and leaving 123,829 shares worth $30.3M. The position accounts for 2.25% of the portfolio, ranked #8.

Van Hulzen Asset Management first reported a position in JNJ in Q4 2013 and has held it in 48 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Van Hulzen Asset Management held 123,829 shares of Johnson & Johnson worth $30.3M as of Q1 2026.
  • Van Hulzen Asset Management sold 5,441 Johnson & Johnson shares in Q1 2026, an estimated $1.27M.
  • Johnson & Johnson made up 2.25% of Van Hulzen Asset Management's portfolio in Q1 2026, its #8 holding.
  • Van Hulzen Asset Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 48 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Van Hulzen Asset Management's 13F filing for Q1 2026, filed 14 May 2026.